Package 70518-4081-2

{"route": ["ORAL"], "spl_id": "4c99c0d5-3b4e-de4b-e063-6294a90a822c", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["6087100f-3ba4-412e-b08d-768d1dcdaf00"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4081-1)", "package_ndc": "70518-4081-1", "marketing_start_date": "20240926"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4081-2)", "package_ndc": "70518-4081-2", "marketing_start_date": "20250701"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4081-3)", "package_ndc": "70518-4081-3", "marketing_start_date": "20250701"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4081-4)", "package_ndc": "70518-4081-4", "marketing_start_date": "20250827"}], "brand_name": "Bupropion hydrochloride", "product_id": "70518-4081_4c99c0d5-3b4e-de4b-e063-6294a90a822c", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70518-4081", "generic_name": "Bupropion hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA216800", "marketing_category": "ANDA", "marketing_start_date": "20240516", "listing_expiration_date": "20271231"}